A group of researchers from Kyoto University have successfully visualized RNA behaviour and its response to drugs within the living tissue brain of live mice by labeling specific RNA molecules with fluorescent probes. The team state that their study can potentially lead to faster, and more accurate screening processes for the discovery and development of new drugs. The opensource study is published in the journal Nucleic Acids Research.
Previous studies show that RNA is a molecule that plays a key role within a living organism, holding information as to when, where and how much protein must be allocated, which is also responsible for controlling the biological reactions within a living cell. RNAs behave uniquely and are distributed unequally in each cell, existing more in some areas of the cell than others depending on environmental factors and cell conditions. In some cases, these chemical changes can put the cell’s health at risk due to RNA disruption. However, it is unclear as to how the distribution of RNA molecules is regulated in the cell, and what causes them to act abnormally.
The current study introduced fluorescent probe within the brain of live mice, the team succeeded in visualizing targeted RNA in the cell nucleus. The researchers explain that this fluorescent probe emits varying intensities of light depending on RNA concentration levels enabling them to effectively quantitatively analyze RNA in the living body. The data findings show that the imaging technique quantitatively conveyed that the RNA behaviour in live tissue differed from that of a cultured cell when a drug was administered.
The team hope that this new imaging technique can help reveal the natural state of RNA and allows them to observe the emergence and disappearance of RNA clusters in many types of species, including those that cannot be genetically engineered. The researchers next goal is to investigate differences of RNA activity in a live, single cell, and what regulates RNA activity. They also plan to compare healthy and unhealthy tissue to elucidate gene expression mechanisms caused by abnormal RNA activity.
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.